SVB Leerink Lowers Amedisys (NASDAQ:AMED) Price Target to $96.00
Amedisys (NASDAQ:AMED - Get Rating) had its price target dropped by investment analysts at SVB Leerink ...
Read moreAmedisys (NASDAQ:AMED - Get Rating) had its price target dropped by investment analysts at SVB Leerink ...
Read moreAmryt Pharma (NASDAQ:AMYT - Get Rating)'s stock had its "outperform" rating reissued by research analysts at ...
Read more© 2022 TheDailyStock.News